The AQP4‐mediated glymphatic system has been shown to play a critical role in the clearance of Aβ and Tau proteins in Alzheimer's disease (Harrison et al., 2020; Peng et al., 2016), but its role in hematoma clearance following ICH has not yet been clearly elucidated. Here, MAPT is linked to Alzheimer disease.